Company announcements · 05/11/20261 min read
ANI Pharmaceuticals announces an offer to acquire Egetis Therapeutics, expanding the scope and scale of its Rare Disease business
Summary
PRINCETON, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) announces a recommended public offer to acquire Egetis Therapeutics AB (publ) (Egetis) (the...